Avsar.

Healthcare · Healthcare Research, Analytics & Technology

Indegene Ltd (INDGN)

₹492.65

Mkt cap
₹11,869 Cr
P/E ratio
28.60
P/B
3.79
Div yield
0.46%
ROE
14.40%
ROCE
18.80%
EPS (TTM)
₹17.23
Book value
₹130
52W range
424–590
Sector
Healthcare

Incorporated in 1998, Indegene Ltd provides solutions consisting of analytics, technology and commercial, medical, regulatory and safety services to life science and health care organizations [1]

NSE INDGNBSE 544172www.indegene.com
Health check
Constructive
ValuationCheap
ProfitabilityAverage
GrowthHigh
TechnicalsNeutral
52-week range
−16.44% from high
₹493
₹424+16.33% from low₹590
Current
₹492.65
Prev close
₹495.00
Day
−0.47%
Price performance
1D
−0.47%
1W
−3.23%
1M
−4.90%
3M
+0.18%
6M
+2.65%
1Y
−14.52%
YTD
−5.72%

Financials

F
Revenue, profit & margin
P/E ratio
28.6×
INDGN is 26% below the sector median of 38.6×
INDGN28.6×
Sector median38.6×
 Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Trend
Sales6326086366736736766877207567618049421,003
Expenses535511515524534548561589608606664783840
Operating Profit9797121149139129126132148155141160164
OPM %15%16%19%22%21%19%18%18%20%20%17%17%16%
Other Income132812132622213826222019-10
Interest1213121212124334457
Depreciation20202018182019202122234042
Profit before tax7992101132134120124146149152133135105
Tax %38%26%25%25%29%27%26%25%21%23%23%24%24%
Net Profit4968759995889211011811610210380
EPS in Rs2.203.083.384.454.263.673.834.584.904.854.254.283.31
Raw PDF

Earnings

EResults dates & reactions
Next results
30 Jul '26scheduled

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

No reaction history yet.
No quarterly filings ingested yet.

Corporate actions

CLast 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

Sas of Jun 2026
FIIs9.92%0.35
DIIs8.74%0.45
Public81.34%0.09
Ownership trend

Peers

P7 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Syngene Intl.₹406.6545.5516,4150.31%148−11.82%960+1.22%9.91%
Indegene₹492.6528.6311,8690.46%80−19.14%1,003+32.80%18.82%
Suven Life Scie.₹316.00—8,9290.00%−46−3.78%2+3.40%−76.92%
Vimta Labs₹570.4531.552,5490.35%21+11.38%109+11.80%25.23%
Fabtech Tech.₹149.7313.696660.00%4+154.79%75+10.25%13.58%
Take Solutions₹20.7972.193080.00%4+1,353.33%54—18.51%
Novelix Pharma.₹69.9977.841990.00%1+405.56%25+20.76%9.98%
Median: 9 Co.₹149.7338.556660.00%4+154.79%75+11.03%9.98%

Filings

D
Annual reports3
Financial Year 2026bseFinancial Year 2025bseFinancial Year 2024bse
Concall transcripts28
PPTMay 2026TranscriptMay 2026PPTMay 2026RECMay 2026PPTApr 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026TranscriptNov 2025PPTNov 2025TranscriptOct 2025PPTOct 2025RECOct 2025TranscriptAug 2025PPTAug 2025TranscriptMay 2025PPTMay 2025RECMay 2025PPTMar 2025TranscriptFeb 2025PPTFeb 2025TranscriptNov 2024PPTNov 2024TranscriptAug 2024
Announcements5
Announcement under Regulation 30 (LODR)-Newspaper Publication 18 JulLetter To Shareholders In Relation To Annual Report Of The Company For The Financial Year 2025-26 17 Jul - Indegene schedules 28th AGM on 13 August 2026 and shares FY26 annual report link.Business Responsibility and Sustainability Reporting (BRSR) 17 Jul - Indegene filed its FY 2025-26 BRSR as part of the annual report.Reg. 34 (1) Annual Report. 17 Jul - Indegene issued FY2025-26 annual report, AGM notice for 13 August 2026, and ₹2.25 final dividend proposal.Notice Of The 28Th Annual General Meeting Of The Company 17 Jul